| |
| |
|
| Insider
Information: |
Jaen Juan C. |
| Relationship: |
President |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
371,475 |
|
|
Indirect Shares
|
1,188,233 |
|
|
| Direct
Value |
$6,852,563 |
|
|
|
Indirect Value
|
$18,417,612 |
|
|
| Total
Shares |
1,559,708 |
|
|
| Total
Value |
$25,270,174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -71.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-17 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-18 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-04 |
4 |
OE |
$4.30 |
$16,663 |
D/D |
3,875 |
56,100 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-12 |
4 |
OE |
$4.30 |
$14,212 |
D/D |
3,305 |
56,305 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-01-29 |
4 |
OE |
$4.30 |
$21,036 |
D/D |
4,892 |
57,892 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-10-01 |
4 |
AS |
$11.98 |
$25,157 |
D/D |
(2,100) |
60,833 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-27 |
4 |
AS |
$11.95 |
$3,586 |
D/D |
(300) |
62,933 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-25 |
4 |
AS |
$11.96 |
$88,480 |
D/D |
(7,401) |
63,233 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-24 |
4 |
AS |
$11.96 |
$32,358 |
D/D |
(2,705) |
70,634 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-21 |
4 |
AS |
$12.01 |
$2,402 |
D/D |
(200) |
73,339 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-20 |
4 |
AS |
$12.01 |
$7,937 |
D/D |
(661) |
73,539 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-09-17 |
4 |
AS |
$12.05 |
$9,638 |
D/D |
(800) |
74,200 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSOOffic |
• – – |
2012-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,000 |
|
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-06-17 |
4 |
S |
$23.68 |
$63,344 |
D/D |
(2,675) |
198,286 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-06-16 |
4 |
S |
$24.13 |
$52,707 |
D/D |
(2,182) |
200,961 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-12-17 |
4 |
S |
$38.79 |
$44,715 |
D/D |
(1,108) |
201,157 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-12-16 |
4 |
S |
$39.59 |
$34,448 |
D/D |
(865) |
202,265 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
19,375 |
208,768 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-06-17 |
4 |
S |
$21.71 |
$56,116 |
D/D |
(2,537) |
210,037 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-06-16 |
4 |
S |
$20.72 |
$48,340 |
D/D |
(2,333) |
212,574 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-12-16 |
4 |
S |
$30.66 |
$136,407 |
D/D |
(4,436) |
218,258 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
232,407 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
244,393 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2023-12-19 |
4 |
D |
$18.09 |
$113,225 |
D/D |
(6,259) |
301,475 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2023-12-18 |
4 |
D |
$17.74 |
$108,711 |
D/D |
(6,128) |
307,734 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
